Out of the FEMS Research and Training Grantees, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) annually selects one grantee for an additional award of € 1000, the FEMS-ESCMID Awardee. Reciprocally, FEMS will provide such additional award to one grantee, the ESCMID-FEMS Awardee. These joint fellowships will receive appropriate publicity through both organizations.
The investigation of novel approaches for tackling the antimicrobial resistance crisis must be part of any global response to this problem if an untimely reversion to the pre-penicillin era of medicine is to be avoided. One such promising avenue of research involves so-called antibiotic resistance breakers (ARBs), capable of re-sensitising resistant bacteria to antibiotics. This review introduces the area of ARB research, summarises the current state of ARB development with emphasis on the various major classes of ARBs currently being investigated and their modes of action, and offers a perspective on the future direction of the field.